Attention Deficit Hyperactivity Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Attention Deficit Hyperactivity Disorder stocks.

Attention Deficit Hyperactivity Disorder Stocks Recent News

Date Stock Title
May 20 LLY Dow Jones Futures: Market Extends Losing Streak, Tesla Breaks Down; What You Must Do Now
May 20 LLY Eli Lilly's new diabetes drug Mounjaro priced below Novo Nordisk's Wegovy
May 20 LLY S&P 500 Falls For 7th Consecutive Week Amid Ongoing Inflation, Federal Reserve Rate Hike Fears
May 20 LLY CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss
May 20 LLY Eli Lilly Gets Positive Opinion for Olumiant in Europe. The Stock Rises.
May 20 LLY Radius (RDUS), Menarini Post Positive Data on Breast Cancer Drug
May 20 LLY Lilly, Incyte's Olumiant get EMA panel nod for hair loss disorder alopecia areata
May 20 LLY Dow Jones Rallies As China Cuts Key Interest Rate; Ross Stores Plummets 22% On Earnings
May 20 LLY Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo
May 20 LLY Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide
May 20 LLY CHMP Recommends Approval of Lilly and Incyte's OLUMIANT® (baricitinib) as the First and Only Centrally-Authorized Treatment for Adults with Severe Alopecia Areata (AA)
May 20 LLY Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
May 19 CING Cingulate wants to be the next Eli Lilly — and stay in Kansas City
May 19 LLY Eli Lilly oncologic selpercatinib granted Orphan Drug status for solid tumors
May 19 LLY 4 Large Drug Stocks to Watch as the Industry Recovers
May 19 DRRX Executives Buy Around $17M Of 5 Penny Stocks
May 19 LLY Dow Jones Futures Sell Off After Stock Market Dive; Cisco Plunges 12% On Earnings
May 19 LLY PepsiCo And 3 Other Stocks Insiders Are Selling
May 18 RGC Sector Rotation And 9 Stocks To Watch During A Recession
May 18 CING Cingulate to Present at H.C. Wainwright Global Investment Conference

Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type. It is characterized by difficulty paying attention, excessive activity, or difficulty controlling behavior which is not appropriate for a person's age. The symptoms appear before a person is twelve years old, are present for more than six months, and may cause problems in at least two settings (such as school, home, or recreational activities). In children, problems paying attention may result in poor school performance. Additionally there is an association with other mental disorders and substance misuse. Although it causes impairment, particularly in modern society, many people with ADHD can have sustained attention span for tasks they find interesting or rewarding (known as hyperfocus).Despite being the most commonly studied and diagnosed mental disorder in children and adolescents, the exact cause is unknown in the majority of cases. It affects about 5–7% of children when diagnosed via the DSM-IV criteria and 1–2% when diagnosed via the ICD-10 criteria. As of 2015 it is estimated to affect about 51.1 million people globally. Rates are similar between countries and depend mostly on how it is diagnosed. ADHD is diagnosed approximately two times more often in boys than in girls, although the disorder is often overlooked in girls because their symptoms differ from those of boys. About 30–50% of people diagnosed in childhood continue to have symptoms into adulthood and between 2–5% of adults have the condition. In adults inner restlessness rather than hyperactivity may occur. The condition can be difficult to tell apart from other conditions, as well as to distinguish from high levels of activity that are still within the range of normative behaviors.ADHD management recommendations vary by country and usually involve some combination of counseling, lifestyle changes, and medications. The British guideline only recommends medications as a first-line treatment in children who have severe symptoms and for medication to be considered in those with moderate symptoms who either refuse or fail to improve with counseling, though for adults medications are a first-line treatment. Canadian and American guidelines recommend that medications and behavioral therapy be used together as a first-line therapy, except in preschool-aged children. Stimulant medication therapy is not recommended as a first-line therapy in preschool-aged children in either guideline. Treatment with stimulants is effective for at least 14 months; however, their long term effectiveness is unclear. Adults often develop coping skills which make up for some or all of their impairments.The medical literature has described symptoms similar to those of ADHD since the 18th century. ADHD, its diagnosis, and its treatment have been considered controversial since the 1970s. The controversies have involved clinicians, teachers, policymakers, parents, and the media. Topics include ADHD's causes and the use of stimulant medications in its treatment. Most healthcare providers accept ADHD as a genuine disorder in children and adults, and the debate in the scientific community mainly centers on how it is diagnosed and treated. The condition was officially known as attention-deficit disorder (ADD) from 1980 to 1987, while before this it was known as hyperkinetic reaction of childhood.

More about Attention Deficit Hyperactivity Disorder
Browse All Tags